Emerging antibodies for the treatment of pancreatic cancer
Author:
Affiliation:
1. Division of Medical Oncology, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena, Modena, Italy
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Pharmacology
Link
https://www.tandfonline.com/doi/pdf/10.1080/14728214.2017.1293649
Reference87 articles.
1. Pancreatic Adenocarcinoma
2. European cancer mortality predictions for the year 2014
3. Risk factors for pancreatic cancer: a summary review of meta-analytical studies
4. Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Three-Dimensional Modeling of Solid Tumors and Their Microenvironment to Evaluate T Cell Therapy Efficacy In Vitro;The Journal of Immunology;2023-06-09
2. Cephalic Pancreatoduodenectomy (CPD) Performed for Pancreatic Head Adenocarcinoma in a 72 Year- Old Patient - Case Presentation;2021 International Conference on e-Health and Bioengineering (EHB);2021-11-18
3. Antibody therapy in pancreatic cancer: mAb-ye we’re onto something?;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2021-08
4. Noncoding RNAs in drug-resistant pancreatic cancer: A review;Biomedicine & Pharmacotherapy;2020-11
5. Engineered T Cell Therapy for Cancer in the Clinic;Frontiers in Immunology;2019-10-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3